Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

BioMarin Pharmaceutical Revenue 2010-2025 | BMRN

BioMarin Pharmaceutical annual/quarterly revenue history and growth rate from 2010 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • BioMarin Pharmaceutical revenue for the quarter ending March 31, 2025 was $0.745B, a 14.84% increase year-over-year.
  • BioMarin Pharmaceutical revenue for the twelve months ending March 31, 2025 was $2.950B, a 19.36% increase year-over-year.
  • BioMarin Pharmaceutical annual revenue for 2024 was $2.854B, a 17.97% increase from 2023.
  • BioMarin Pharmaceutical annual revenue for 2023 was $2.419B, a 15.42% increase from 2022.
  • BioMarin Pharmaceutical annual revenue for 2022 was $2.096B, a 13.53% increase from 2021.
  
BioMarin Pharmaceutical Annual Revenue
(Millions of US $)
2024 $2,854
2023 $2,419
2022 $2,096
2021 $1,846
2020 $1,860
2019 $1,704
2018 $1,491
2017 $1,314
2016 $1,117
2015 $890
2014 $749
2013 $548
2012 $501
2011 $441
2010 $376
2009 $325
BioMarin Pharmaceutical Quarterly Revenue
(Millions of US $)
2025-03-31 $745
2024-12-31 $747
2024-09-30 $746
2024-06-30 $712
2024-03-31 $649
2023-12-31 $646
2023-09-30 $581
2023-06-30 $595
2023-03-31 $596
2022-12-31 $538
2022-09-30 $505
2022-06-30 $534
2022-03-31 $519
2021-12-31 $450
2021-09-30 $409
2021-06-30 $502
2021-03-31 $486
2020-12-31 $452
2020-09-30 $477
2020-06-30 $429
2020-03-31 $502
2019-12-31 $454
2019-09-30 $461
2019-06-30 $388
2019-03-31 $401
2018-12-31 $353
2018-09-30 $392
2018-06-30 $373
2018-03-31 $373
2017-12-31 $358
2017-09-30 $334
2017-06-30 $317
2017-03-31 $304
2016-12-31 $300
2016-09-30 $280
2016-06-30 $300
2016-03-31 $237
2015-12-31 $228
2015-09-30 $209
2015-06-30 $250
2015-03-31 $203
2014-12-31 $229
2014-09-30 $177
2014-06-30 $192
2014-03-31 $152
2013-12-31 $147
2013-09-30 $137
2013-06-30 $137
2013-03-31 $128
2012-12-31 $132
2012-09-30 $128
2012-06-30 $124
2012-03-31 $117
2011-12-31 $108
2011-09-30 $113
2011-06-30 $111
2011-03-31 $109
2010-12-31 $102
2010-09-30 $98
2010-06-30 $92
2010-03-31 $85
2009-12-31 $87
2009-09-30 $81
2009-06-30 $83
2009-03-31 $74
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $11.461B $2.854B
BioMarin Pharmaceutical Inc. focuses on the development and commercialization of treatments for serious life-threatening medical conditions, mostly for children. The company's portfolio comprises seven marketed products namely, Aldurazyme, Naglazyme, Kuvan a rare genetic enzyme deficiency disorder), Vimizim , Brineura, Palynziq and Voxzogo. BioMarin has a collaboration agreement with Sanofi's subsidiary Genzyme for Aldurazyme. Genzyme is BioMarin's sole customer for Aldurazyme and is responsible for marketing and selling Aldurazyme to third parties.?The newest drug in BioMarin's portfolio, Voxzogo for treating achondroplasia, the most common form of dwarfism. BioMarin's biologics license application (BLA) for Roctavian/valoctocogene roxaparvovec (valrox), a gene therapy for severe hemophilia A, was given a complete response letter (CRL) by the FDA.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $228.507B 17.06
Amgen (AMGN) United States $165.909B 14.86
Gilead Sciences (GILD) United States $140.813B 14.62
Vertex Pharmaceuticals (VRTX) United States $121.278B 0.00
Bristol Myers Squibb (BMY) United States $99.597B 6.67
CSL (CSLLY) Australia $86.179B 0.00
GSK (GSK) United Kingdom $78.270B 9.37
Regeneron Pharmaceuticals (REGN) United States $60.962B 14.80
Alnylam Pharmaceuticals (ALNY) United States $42.767B 0.00
Argenex SE (ARGX) Netherlands $36.214B 98.62
BioNTech SE (BNTX) Germany $27.542B 0.00
Royalty Pharma (RPRX) United States $20.572B 8.69
Insmed (INSM) United States $19.639B 0.00
Biogen (BIIB) United States $19.428B 8.38
Illumina (ILMN) United States $17.039B 32.32
Genmab (GMAB) Denmark $15.160B 17.00
Genmab (GNMSF) Denmark $14.867B 15.20
Incyte (INCY) United States $13.645B 103.66
Moderna (MRNA) United States $13.153B 0.00
Exelixis (EXEL) United States $12.215B 20.74
QIAGEN (QGEN) Netherlands $11.388B 22.16
Swedish Orphan Biovitrum (BIOVF) Sweden $10.605B 23.46
Ascendis Pharma (ASND) Denmark $10.292B 0.00
Exact Sciences (EXAS) United States $9.200B 0.00
Bio-Techne Corp (TECH) United States $9.166B 34.19
Verona Pharma American Depositary Share (VRNA) United Kingdom $8.939B 0.00
Legend Biotech (LEGN) United States $8.124B 0.00
Roivant Sciences (ROIV) United Kingdom $7.736B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $7.506B 0.00
Halozyme Therapeutics (HALO) United States $7.242B 13.86
Anbio Biotechnology (NNNN) Germany $7.153B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.141B 7.01
Revolution Medicines (RVMD) United States $6.933B 0.00
Repligen (RGEN) United States $6.847B 76.65
Bio-Rad Laboratories (BIO.B) United States $6.723B 23.40
Nuvalent (NUVL) United States $5.894B 0.00
TG Therapeutics (TGTX) United States $5.799B 152.21
CRISPR Therapeutics AG (CRSP) Switzerland $5.705B 0.00
Guardant Health (GH) United States $5.636B 0.00
Rhythm Pharmaceuticals (RYTM) United States $5.552B 0.00
Axsome Therapeutics (AXSM) United States $5.168B 0.00
Telix Pharmaceuticals (TLX) Australia $4.700B 0.00
Vaxcyte (PCVX) United States $4.675B 0.00
Merus (MRUS) Netherlands $4.547B 0.00
Cytokinetics (CYTK) United States $4.456B 0.00
Abivax SA (ABVX) France $4.428B 0.00
Alkermes (ALKS) Ireland $4.375B 11.74
Zealand Pharma (ZLDPF) Denmark $4.336B 0.00
Krystal Biotech (KRYS) United States $4.335B 33.41
Zai Lab (ZLAB) China $4.195B 0.00
Metsera (MTSR) United States $4.166B 0.00
ADMA Biologics Inc (ADMA) United States $4.132B 30.91
Akero Therapeutics (AKRO) United States $4.027B 0.00
Avidity Biosciences (RNA) United States $4.002B 0.00
Arcellx (ACLX) United States $3.872B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.858B 33.90
Viking Therapeutics (VKTX) United States $3.767B 0.00
Scholar Rock Holding (SRRK) United States $3.713B 0.00
PTC Therapeutics (PTCT) United States $3.671B 6.39
MoonLake Immunotherapeutics (MLTX) Switzerland $3.523B 0.00
Ascentage Pharma Group - (AAPG) China $3.469B 0.00
Protagonist Therapeutics (PTGX) United States $3.331B 71.65
Immunovant (IMVT) United States $3.134B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.101B 0.00
Kymera Therapeutics (KYMR) United States $2.986B 0.00
Bavarian Nordic (BVNRY) Denmark $2.870B 15.16
Alvotech (ALVO) Luxembourg $2.762B 15.79
ImmunityBio (IBRX) United States $2.657B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.584B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.581B 0.00
Ligand Pharmaceuticals (LGND) United States $2.563B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.545B 0.00
Apellis Pharmaceuticals (APLS) United States $2.525B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.380B 0.00
Agios Pharmaceuticals (AGIO) United States $2.296B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.246B 0.00
IDEAYA Biosciences (IDYA) United States $2.175B 0.00
Mesoblast (MESO) Australia $2.170B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.108B 14.01
Beam Therapeutics (BEAM) United States $2.107B 0.00
Twist Bioscience (TWST) United States $2.102B 0.00
Disc Medicine (IRON) United States $2.098B 0.00
Denali Therapeutics (DNLI) United States $2.079B 0.00
Vericel (VCEL) United States $2.000B 1324.00
CG Oncology (CGON) United States $1.993B 0.00
Belite Bio (BLTE) United States $1.969B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.963B 0.00
Amicus Therapeutics (FOLD) United States $1.934B 209.33
Apogee Therapeutics (APGE) United States $1.917B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.790B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.783B 0.00
Certara (CERT) United States $1.781B 33.27
Immunocore Holdings (IMCR) United Kingdom $1.772B 0.00
Adaptive Biotechnologies (ADPT) United States $1.619B 0.00
Liquidia Technologies (LQDA) United States $1.605B 0.00
Celldex Therapeutics (CLDX) United States $1.541B 0.00
Edgewise Therapeutics (EWTX) United States $1.539B 0.00
Janux Therapeutics (JANX) United States $1.537B 0.00
AbCellera Biologics (ABCL) Canada $1.498B 0.00
89BIO (ETNB) United States $1.457B 0.00
ANI Pharmaceuticals (ANIP) United States $1.446B 14.90
GRAIL (GRAL) United States $1.429B 0.00
Viridian Therapeutics (VRDN) United States $1.427B 0.00
Travere Therapeutics (TVTX) United States $1.416B 0.00
NovoCure (NVCR) Jersey $1.398B 0.00
Biohaven (BHVN) United States $1.398B 0.00
Vera Therapeutics (VERA) United States $1.395B 0.00
Cogent Biosciences (COGT) United States $1.388B 0.00
Dynavax Technologies (DVAX) United States $1.340B 79.71
Intellia Therapeutics (NTLA) United States $1.324B 0.00
WAVE Life Sciences (WVE) Singapore $1.305B 0.00
Cidara Therapeutics (CDTX) United States $1.267B 0.00
Sarepta Therapeutics (SRPT) United States $1.266B 0.00
MannKind (MNKD) United States $1.240B 25.50
Novavax (NVAX) United States $1.237B 2.88
CureVac (CVAC) Germany $1.220B 5.91
Praxis Precision Medicines (PRAX) United States $1.182B 0.00
Sana Biotechnology (SANA) United States $1.157B 0.00
Iovance Biotherapeutics (IOVA) United States $1.099B 0.00
Anavex Life Sciences (AVXL) United States $1.088B 0.00
BGM Group (BGM) China $1.065B 0.00
Spyre Therapeutics (SYRE) United States $1.061B 0.00
Pharvaris (PHVS) Netherlands $1.048B 0.00
Structure Therapeutics (GPCR) United States $1.048B 0.00
Arcus Biosciences (RCUS) United States $1.045B 0.00
MiMedx (MDXG) United States $1.012B 24.46
Pacira BioSciences (PCRX) United States $1.010B 9.61
Oric Pharmaceuticals (ORIC) United States $1.000B 0.00
Immunome (IMNM) United States $0.978B 0.00
Zymeworks (ZYME) United States $0.976B 0.00
LENZ Therapeutics (LENZ) United States $0.940B 0.00
Mineralys Therapeutics (MLYS) United States $0.929B 0.00
Trevi Therapeutics (TRVI) United States $0.920B 0.00
Jyong Biotech (MENS) Taiwan $0.896B 0.00
Nurix Therapeutics (NRIX) United States $0.881B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.872B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.860B 0.00
Nuvation Bio (NUVB) United States $0.854B 0.00
Sionna Therapeutics (SION) United States $0.845B 0.00
UniQure (QURE) Netherlands $0.833B 0.00
Urogen Pharma (URGN) United States $0.832B 0.00
NeoGenomics (NEO) United States $0.826B 0.00
Geron (GERN) United States $0.815B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.808B 0.00
Vir Biotechnology (VIR) United States $0.796B 0.00
AnaptysBio (ANAB) United States $0.793B 0.00
Immatics (IMTX) Germany $0.784B 0.00
CorMedix Inc (CRMD) United States $0.780B 52.27
Pharming Group (PHGUF) Netherlands $0.772B 0.00
Oculis Holding AG (OCS) Switzerland $0.771B 0.00
GH Research (GHRS) Ireland $0.754B 0.00
Stoke Therapeutics (STOK) United States $0.738B 17.10
Mind Medicine (MindMed) (MNMD) United States $0.734B 0.00
ArriVent BioPharma (AVBP) United States $0.734B 0.00
Tango Therapeutics (TNGX) United States $0.732B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.731B 0.00
Niagen Bioscience (NAGE) United States $0.730B 103.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.722B 0.00
Maze Therapeutics (MAZE) United States $0.720B 0.00
Upstream Bio (UPB) United States $0.718B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.703B 0.00
Dianthus Therapeutics (DNTH) United States $0.701B 0.00
Pharming Group (PHAR) Netherlands $0.698B 0.00
Gyre Therapeutics (GYRE) United States $0.692B 184.50
Zenas BioPharma (ZBIO) United States $0.683B 0.00
MeiraGTx Holdings (MGTX) United States $0.668B 0.00
Bicara Therapeutics (BCAX) United States $0.651B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.632B 0.00
Arbutus Biopharma (ABUS) United States $0.621B 0.00
Rapport Therapeutics (RAPP) United States $0.607B 0.00
Septerna (SEPN) United States $0.604B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.596B 0.00
Fortrea Holdings (FTRE) United States $0.589B 16.27
Prime Medicine (PRME) United States $0.585B 0.00
Keros Therapeutics (KROS) United States $0.584B 0.00
Arvinas (ARVN) United States $0.576B 0.00
Tyra Biosciences (TYRA) United States $0.572B 0.00
Kura Oncology (KURA) United States $0.560B 0.00
Sage Therapeutics (SAGE) United States $0.549B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.548B 0.00
Celcuity (CELC) United States $0.532B 0.00
Terns Pharmaceuticals (TERN) United States $0.529B 0.00
Opthea (OPT) Australia $0.525B 0.00
Solid Biosciences (SLDB) United States $0.518B 0.00
Rezolute (RZLT) United States $0.511B 0.00
ATyr Pharma (ATYR) United States $0.494B 0.00
Cullinan Therapeutics (CGEM) United States $0.492B 0.00
Erasca (ERAS) United States $0.484B 0.00
Castle Biosciences (CSTL) United States $0.474B 32.22
Precigen (PGEN) United States $0.472B 0.00
REGENXBIO (RGNX) United States $0.458B 0.00
PureTech Health (PRTC) United States $0.456B 0.00
Absci (ABSI) United States $0.448B 0.00
Kamada (KMDA) Israel $0.447B 26.83
Compass Therapeutics (CMPX) United States $0.437B 0.00
MBX Biosciences (MBX) United States $0.436B 0.00
Kodiak Sciences (KOD) United States $0.435B 0.00
Myriad Genetics (MYGN) United States $0.429B 0.00
Palvella Therapeutics (PVLA) United States $0.427B 0.00
Fulcrum Therapeutics (FULC) United States $0.422B 0.00
Cytek Biosciences (CTKB) United States $0.422B 0.00
Tectonic Therapeutic (TECX) United States $0.416B 0.00
Humacyte (HUMA) United States $0.414B 0.00
Eton Pharmaceuticals (ETON) United States $0.412B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.408B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.405B 0.00
Emergent Biosolutions (EBS) United States $0.405B 0.00
Gossamer Bio (GOSS) United States $0.405B 0.00
ITeos Therapeutics (ITOS) United States $0.388B 0.00
Vigil Neuroscience (VIGL) United States $0.384B 0.00
Neumora Therapeutics (NMRA) United States $0.370B 0.00
Astria Therapeutics (ATXS) United States $0.370B 0.00
Northwest Biotherapeutics (NWBO) United States $0.368B 0.00
Prothena (PRTA) Ireland $0.361B 0.00
Aura Biosciences (AURA) United States $0.355B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.351B 71.38
Candel Therapeutics (CADL) United States $0.351B 0.00
Cartesian Therapeutics (RNAC) United States $0.349B 0.00
Foghorn Therapeutics (FHTX) United States $0.345B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.343B 0.00
Abeona Therapeutics (ABEO) United States $0.340B 0.00
Inhibrx Biosciences (INBX) United States $0.334B 0.20
Allogene Therapeutics (ALLO) United States $0.330B 0.00
Ocugen (OCGN) United States $0.327B 0.00
Neurogene (NGNE) United States $0.325B 0.00
Inventiva S.A (IVA) France $0.324B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.324B 0.00
Amarin (AMRN) Ireland $0.321B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.320B 0.00
Atea Pharmaceuticals (AVIR) United States $0.320B 0.00
Sagimet Biosciences (SGMT) United States $0.313B 0.00
Olema Pharmaceuticals (OLMA) United States $0.313B 0.00
Benitec Biopharma (BNTC) United States $0.313B 0.00
XOMA Royalty (XOMA) United States $0.309B 0.00
ScPharmaceuticals (SCPH) United States $0.308B 0.00
Aardvark Therapeutics (AARD) United States $0.292B 0.00
Verastem (VSTM) United States $0.291B 0.00
Monopar Therapeutics (MNPR) United States $0.286B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.282B 0.00
Annexon (ANNX) United States $0.280B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.277B 0.00
Alpha Teknova (TKNO) United States $0.276B 0.00
Cardiff Oncology (CRDF) United States $0.275B 0.00
Editas Medicine (EDIT) United States $0.273B 0.00
Lifecore Biomedical (LFCR) United States $0.272B 0.00
Vor Biopharma (VOR) $0.271B 0.00
Codexis (CDXS) United States $0.268B 0.00
DBV Technologies S.A (DBVT) France $0.268B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.262B 0.00
Tvardi Therapeutics (TVRD) United States $0.255B 0.00
Crescent Biopharma (CBIO) United States $0.255B 0.00
Prima BioMed (IMMP) Australia $0.248B 0.00
Third Harmonic Bio (THRD) United States $0.245B 0.00
AC Immune (ACIU) Switzerland $0.244B 0.00
Entrada Therapeutics (TRDA) United States $0.243B 7.89
MaxCyte (MXCT) United States $0.242B 0.00
Adherex Technologies (FENC) United States $0.241B 0.00
Replimune (REPL) United States $0.239B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.238B 0.00
Design Therapeutics (DSGN) United States $0.229B 0.00
Ventyx Biosciences (VTYX) United States $0.228B 0.00
Bright Minds Biosciences (DRUG) United States $0.225B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.223B 0.00
Caribou Biosciences (CRBU) United States $0.220B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.219B 0.00
Adocia (ADOCY) France $0.216B 0.00
Instil Bio (TIL) United States $0.211B 0.00
Alumis (ALMS) United States $0.210B 0.00
DiaMedica Therapeutics (DMAC) United States $0.209B 0.00
Rapt Therapeutics (RAPT) United States $0.209B 0.00
CARGO Therapeutics (CRGX) United States $0.208B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.203B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.199B 0.00
GENFIT S.A (GNFT) France $0.199B 0.00
BioStem Technologies (BSEM) $0.199B 8.07
Semper Paratus Acquisition (TVGN) United States $0.197B 0.00
CytomX Therapeutics (CTMX) United States $0.193B 4.98
EnGene Holdings (ENGN) Canada $0.189B 0.00
Innate Pharma S.A (IPHA) France $0.188B 0.00
Kyverna Therapeutics (KYTX) United States $0.183B 0.00
Voyager Therapeutics (VYGR) United States $0.183B 0.00
SELLAS Life Sciences (SLS) United States $0.183B 0.00
Alector (ALEC) United States $0.179B 0.00
Black Diamond Therapeutics (BDTX) United States $0.177B 52.00
I-Mab (IMAB) United States $0.173B 0.00
Puma Biotechnology (PBYI) United States $0.169B 4.42
BioAge Labs (BIOA) United States $0.168B 0.00
Agenus (AGEN) United States $0.166B 0.00
C4 Therapeutics (CCCC) United States $0.163B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.162B 0.00
Anika Therapeutics (ANIK) United States $0.162B 0.00
Nuvectis Pharma (NVCT) United States $0.162B 0.00
Molecular Partners AG (MOLN) Switzerland $0.161B 0.00
Alpha Cognition (ACOG) Canada $0.160B 0.00
Elicio Therapeutics (ELTX) United States $0.157B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.157B 0.00
Greenwich LifeSciences (GLSI) United States $0.154B 0.00
Citius Oncology (CTOR) United States $0.153B 0.00
Nkarta (NKTX) United States $0.152B 0.00
Contineum Therapeutics (CTNM) United States $0.147B 0.00
Theratechnologies (THTX) Canada $0.145B 0.00
Immuneering (IMRX) United States $0.144B 0.00
Fate Therapeutics (FATE) United States $0.143B 0.00
Tenaya Therapeutics (TNYA) United States $0.141B 0.00
Sangamo Therapeutics (SGMO) United States $0.139B 0.00
Compugen (CGEN) Israel $0.137B 0.00
Actuate Therapeutics (ACTU) United States $0.137B 0.00
23andMe Holding (MEHCQ) United States $0.134B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.133B 0.00
Spero Therapeutics (SPRO) United States $0.131B 0.00
Genelux (GNLX) United States $0.131B 0.00
Connect Biopharma Holdings (CNTB) United States $0.131B 0.00
BioHarvest Sciences (BHST) Canada $0.129B 0.00
Seer (SEER) United States $0.128B 0.00
IO Biotech (IOBT) Denmark $0.127B 0.00
Skye Bioscience (SKYE) United States $0.124B 0.00
TuHURA Biosciences (HURA) United States $0.124B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.123B 0.00
Coherus Oncology (CHRS) United States $0.118B 0.00
Seres Therapeutics (MCRB) United States $0.117B 0.00
Zura Bio (ZURA) United States $0.115B 0.00
Coya Therapeutics (COYA) United States $0.112B 0.00
Cellectis S.A (CLLS) France $0.111B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.109B 0.00
Oncolytics Biotech (ONCY) Canada $0.107B 0.00
HilleVax (HLVX) United States $0.107B 0.00
TScan Therapeutics (TCRX) United States $0.106B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.106B 0.00
OKYO Pharma (OKYO) $0.104B 0.00
Immunic (IMUX) United States $0.103B 0.00
Climb Bio (CLYM) United States $0.100B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.098B 0.00
Pliant Therapeutics (PLRX) United States $0.098B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.098B 0.00
Invivyd (IVVD) United States $0.097B 0.00
Nautilus Biotechnology (NAUT) United States $0.096B 0.00
Adagene (ADAG) China $0.094B 0.00
Whitehawk Therapeutics (WHWK) United States $0.091B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.088B 0.00
Entera Bio (ENTX) Israel $0.087B 0.00
XBiotech (XBIT) United States $0.087B 0.00
Quince Therapeutics (QNCX) United States $0.085B 0.00
Cabaletta Bio (CABA) United States $0.084B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.084B 0.00
Artiva Biotherapeutics (ARTV) United States $0.084B 0.00
Alto Neuroscience (ANRO) United States $0.083B 0.00
EXoZymes (EXOZ) United States $0.083B 0.00
VistaGen Therapeutics (VTGN) United States $0.079B 0.00
BeyondSpring (BYSI) United States $0.079B 0.00
Elutia (ELUT) United States $0.078B 0.00
Immix Biopharma (IMMX) United States $0.078B 0.00
Sutro Biopharma (STRO) United States $0.077B 0.00
TELA Bio (TELA) United States $0.077B 0.00
IGM Biosciences (IGMS) United States $0.077B 0.00
MiNK Therapeutics (INKT) United States $0.076B 0.00
Celularity (CELU) United States $0.076B 0.00
Scilex Holding (SCLX) United States $0.075B 0.00
Atara Biotherapeutics (ATRA) United States $0.073B 0.00
Opus Genetics (IRD) United States $0.072B 0.00
Applied Therapeutics (APLT) United States $0.072B 0.00
Forte Biosciences (FBRX) United States $0.071B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.070B 0.00
CervoMed (CRVO) United States $0.070B 0.00
Genenta Science S.p.A (GNTA) Italy $0.070B 0.00
Quantum Biopharma (QNTM) Canada $0.069B 0.00
Cue Biopharma (CUE) United States $0.068B 0.00
Biomea Fusion (BMEA) United States $0.068B 0.00
Oncobiologics (OTLK) United States $0.067B 0.00
Repare Therapeutics (RPTX) Canada $0.066B 0.00
Ikena Oncology (IKNA) United States $0.066B 0.00
INmune Bio (INMB) United States $0.066B 0.00
Adicet Bio (ACET) United States $0.064B 0.00
Werewolf Therapeutics (HOWL) United States $0.061B 0.00
Earth Science Tech (ETST) United States $0.061B 0.00
MediciNova (MNOV) United States $0.061B 0.00
Fortress Biotech (FBIO) United States $0.057B 0.00
InflaRx (IFRX) Germany $0.057B 0.00
Renovaro (RENB) United States $0.056B 0.00
Adverum Biotechnologies (ADVM) United States $0.056B 0.00
Annovis Bio (ANVS) United States $0.056B 0.00
Precision BioSciences (DTIL) United States $0.055B 0.00
Inovio Pharmaceuticals (INO) United States $0.055B 0.00
PDS Biotechnology (PDSB) United States $0.055B 0.00
ABVC BioPharma (ABVC) United States $0.055B 0.00
Aligos Therapeutics (ALGS) United States $0.054B 0.00
VTv Therapeutics (VTVT) United States $0.054B 0.00
Adlai Nortye (ANL) Cayman Islands $0.054B 0.00
Cognition Therapeutics (CGTX) United States $0.053B 0.00
Kalaris Therapeutics (KLRS) United States $0.053B 0.00
Senti Biosciences (SNTI) United States $0.052B 0.00
CalciMedica (CALC) United States $0.052B 0.00
Exicure (XCUR) United States $0.052B 0.00
Alterity Therapeutics - (ATHE) Australia $0.050B 0.00
Ovid Therapeutics (OVID) United States $0.049B 0.00
RenovoRx (RNXT) United States $0.048B 0.00
PepGen (PEPG) United States $0.047B 0.00
Jasper Therapeutics (JSPR) United States $0.047B 0.00
Lantern Pharma (LTRN) United States $0.046B 0.00
KALA BIO (KALA) United States $0.045B 0.00
Grace Therapeutics (GRCE) Canada $0.044B 0.00
Clearside Biomedical (CLSD) United States $0.042B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.042B 0.00
Shattuck Labs (STTK) United States $0.042B 0.00
Medicus Pharma (MDCX) United States $0.041B 0.00
Pluri (PLUR) Israel $0.040B 0.00
Mersana Therapeutics (MRSN) United States $0.040B 0.00
CAMP4 Therapeutics (CAMP) United States $0.039B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.038B 0.00
Radiopharm Theranostics - (RADX) Australia $0.038B 0.00
Xilio Therapeutics (XLO) United States $0.036B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.035B 0.00
Estrella Immunopharma (ESLA) United States $0.034B 0.00
Dyadic (DYAI) United States $0.034B 0.00
AN2 Therapeutics (ANTX) United States $0.033B 0.00
Kezar Life Sciences (KZR) United States $0.033B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.032B 0.00
OnKure Therapeutics (OKUR) United States $0.032B 0.00
Rani Therapeutics Holdings (RANI) United States $0.032B 0.00
Rein Therapeutics (RNTX) United States $0.031B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.031B 0.00
Clene (CLNN) United States $0.030B 0.00
Femasys (FEMY) United States $0.030B 0.00
Promis Neurosciences (PMN) Canada $0.030B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.029B 0.00
ALX Oncology Holdings (ALXO) United States $0.029B 0.00
Q32 Bio (QTTB) United States $0.028B 0.00
Generation Bio (GBIO) United States $0.028B 0.00
Boundless Bio (BOLD) United States $0.028B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.028B 0.00
Cingulate (CING) United States $0.028B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.027B 0.00
FibroBiologics (FBLG) United States $0.026B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.026B 0.00
Tenax Therapeutics (TENX) United States $0.025B 0.00
Longeveron (LGVN) United States $0.025B 0.00
SAB Biotherapeutics (SABS) United States $0.024B 0.00
Aytu BioPharma (AYTU) United States $0.024B 0.00
Dare Bioscience (DARE) United States $0.023B 0.00
Lisata Therapeutics (LSTA) United States $0.023B 0.00
Cadrenal Therapeutics (CVKD) United States $0.022B 0.00
BioAtla (BCAB) United States $0.022B 0.00
Rallybio (RLYB) United States $0.022B 0.00
Chemomab Therapeutics (CMMB) Israel $0.021B 0.00
Lexaria Bioscience (LEXX) Canada $0.020B 0.00
Synlogic (SYBX) United States $0.020B 0.00
Curis (CRIS) United States $0.019B 0.00
Moleculin Biotech (MBRX) United States $0.019B 0.00
Athira Pharma (ATHA) United States $0.018B 0.00
Passage Bio (PASG) United States $0.018B 0.00
Gelteq (GELS) Australia $0.018B 0.00
Hoth Therapeutics (HOTH) United States $0.017B 0.00
Edesa Biotech (EDSA) Canada $0.017B 0.00
Abpro Holdings (ABP) United States $0.016B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.016B 0.00
Allarity Therapeutics (ALLR) United States $0.015B 0.00
Leap Therapeutics (LPTX) United States $0.015B 0.00
MetaVia (MTVA) United States $0.014B 0.00
Beyond Air (XAIR) United States $0.014B 0.00
NextCure (NXTC) United States $0.014B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.013B 0.00
Equillium (EQ) United States $0.013B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.013B 0.00
GeoVax Labs (GOVX) United States $0.013B 0.00
180 Life Sciences (ATNF) United States $0.013B 0.00
BioCardia (BCDA) United States $0.013B 0.00
Bolt Biotherapeutics (BOLT) United States $0.013B 0.00
COSCIENS Biopharma (CSCI) Canada $0.012B 0.00
Synaptogenix (TAOX) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
IBio (IBIO) United States $0.012B 0.00
LakeShore Biopharma (LSB) China $0.012B 0.00
Advanced Biomed (ADVB) United States $0.012B 0.00
Bionano Genomics (BNGO) United States $0.012B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.012B 0.00
Biofrontera (BFRI) United States $0.011B 0.00
HOOKIPA Pharma (HOOK) United States $0.011B 0.00
Imunon (IMNN) United States $0.011B 0.00
Aprea Therapeutics (APRE) United States $0.011B 0.00
X4 Pharmaceuticals (XFOR) United States $0.011B 0.00
BioXcel Therapeutics (BTAI) United States $0.010B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Novogen (KZIA) Australia $0.010B 0.00
BioAffinity Technologies (BIAF) United States $0.010B 0.00
Artelo Biosciences (ARTL) United States $0.010B 0.00
Cyclerion Therapeutics (CYCN) United States $0.010B 0.00
GENPREX (GNPX) United States $0.009B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
Sensei Biotherapeutics (SNSE) United States $0.009B 0.00
Mustang Bio (MBIO) United States $0.009B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
Intensity Therapeutics (INTS) United States $0.008B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.008B 0.00
Polyrizon (PLRZ) Israel $0.007B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
Evogene (EVGN) Israel $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Jade Biosciences (JBIO) United States $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
Apollomics (APLM) United States $0.007B 0.00
Purple Biotech (PPBT) Israel $0.007B 0.00
Portage Biotech (PRTG) $0.006B 0.00
HCW Biologics (HCWB) United States $0.006B 0.00
VivoSim Labs (VIVS) United States $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
Psyence Biomedical (PBM) Canada $0.006B 0.00
BRIACELL THERAP (BCTX) Canada $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Palisade Bio (PALI) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.005B 0.00
Adial Pharmaceuticals (ADIL) United States $0.005B 0.00
GRI Bio (GRI) United States $0.005B 0.00
Titan Pharmaceuticals (TTNP) United States $0.005B 0.00
Revelation Biosciences (REVB) United States $0.005B 0.00
Soligenix (SNGX) United States $0.005B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.004B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Windtree Therapeutics (WINT) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Alzamend Neuro (ALZN) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Onconetix (ONCO) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00